Clinical Trials Browser

Phase 2 × Withdrawn × Leukemia, Promyelocytic, Acute × Clear all

NCT01548911 2018-07-02

Gemtuzumab Ozogamicin in Treating Patients With Acute Myeloid Leukemia

Phase 2 Withdrawn

Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute

NCT00670150 2015-10-27

New Retinoid Agent Combined With Arsenic Trioxide for Untreated Acute Promyelocytic Leukemia

Phase 2 Withdrawn

Other hematologic neoplasm

Leukemia, Promyelocytic, Acute